Dr. Paul Hayashi, MD

• Transplant Hepatology

• Gastroenterology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• National Institutes Of Health Clinical Center

  Fellowship Hospital

• University Of California Davis Medical Center

  Fellowship Hospital

• University Of California, Davis School Of Medicine

  Internship Hospital

• Saint Louis University School Of Medicine

  2006

• University Of Colorado Health Science Center

  Fellowship Hospital, 2003

• University Of Ca

  Medical School, 1987

• Ucla

  Undergraduate School, 1983

• Azathioprine and 6-Mercaptopurine Induced Liver Injury: Clinical Features and Outcomes, 2017-04-25

• Reliability of Causality Assessment for Drug, Herbal and Dietary Supplement Hepatoxicity in the Drug-Induced Liver Injury Network (DILIN), 2014-04-16

• Laboratory test results after living liver donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL), 2011-01-18

• Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset, 2014-03-27

• Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation, 2020-08-24

• Detective Work in Drug-induced Liver Injury: Sometimes It's All about Interviewing the Right Witness, 2010-04-02

• Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury, 2011-02-26

• The Influence of Nonalcoholic Fatty Liver Disease and Its Associated Comorbidities on Liver Transplant Outcomes, 2011-04-27

• Liver transplant recipient survival benefit with living donation in the MELD allocation era, 2011-06-28

• Persistent portosystemic shunts after deceased donor liver transplant causing episodic hepatic encephalopathy despite good graft function, 2009-08-05

• Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury, 2017-08-26

• Paracentesis is Associated with Reduced Mortality in Patients Hospitalized with Cirrhosis and Ascites, 2013-08-24

• Long-Term Outcomes After Drug-Induced Liver Injury, 2018-07-02

• Asparaginase-induced Hepatotoxicity: Rapid Development of Cholestasis and Hepatic Steatosis, 2019-08-07

• Roux-en-Y gastric bypass is associated with increased hazard for de novo alcohol-related complications and liver disease, 2022-02-01

• Focal Fat Masquerading as Malignancy in the Liver Graft of a Post-Transplant Patient, 2011-05-11

• The Impact of Nighttime and Weekend Liver Transplants on Graft and Patient Outcomes, 2012-03-10

• Proton pump inhibitors in cirrhosis: a marker of morbid conditions or cause of mortality, 2019-04-06

• Suboptimal Knowledge of and Surveillance for Hepatocellular Carcinoma by Primary Care Providers, 2014-08-10

• Liver Injury Associated with Kratom, A Popular Opioid-Like Product: Experience from the U.S. Drug Induced liver Injury Network, 2020-11-23

• Declining Liver Graft Quality Threatens the Future of Liver Transplantation in the United States, 2015-05-31

• Trends in characteristics of patients listed for liver transplantation will lead to higher rates of waitlist removal due to clinical deterioration, 2017-06-14

• Liver Injury due to Ashwagandha. A Case Series from Iceland and the U.S. Drug-Induced Liver Injury Network, 2020-02-11

• Surveillance for Hepatocellular Carcinoma in a Medicaid Cirrhotic Population, 2013-02-25

• Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug Induced Liver Injury, 2019-03-29

• Hospitalization Rates Before and After Adult-to-Adult Living Donor or Deceased Donor Liver Transplantation1,2,3, 2011-04-07

• Severe and Protracted Cholestasis in 44 Young Men Taking Body Building Supplements: Assessment of Genetic, Clinical, and Chemical Risk Factors, 2019-04-01

• New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation, 2012-03-10

• Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations, 2013-12-18

• Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series, 2016-05-03

• Medicare/Medicaid Insurance, Rurality and Black Race Associated with Provision of Hepatocellular Carcinoma Treatment and Survival, 2021-02-12

• Long-Term Quality of Life after Liver Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL), 2014-09-06

• Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity, 2015-02-24

• Declining Liver Utilization for Transplant in the United States and the Impact of Donation after Cardiac Death, 2012-09-21

• Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010, 2015-01-23

• Causality Assessment in Drug-Induced Liver Injury Using a Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method, 2011-11-21

• Reduced Impact of Renal Failure on the Outcome of Patients with Alcoholic Liver Disease Undergoing Liver Transplantation, 2016-07-04

• Persistent Liver Biochemistry abnormalities are more common in older patients and those with Cholestatic Drug induced Liver Injury, 2015-09-08

• Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury, 2011-08-16